Fabio Calabrò

5PUBLICATIONS
38CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 29, 2025
Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary Study.

Antonino Guerrisi, Maria Teresa Maccallini, Italia Falcone

|Dec 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri

|Sep 28, 2024
Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab.

Rocco Simone Flammia, Gabriele Tuderti, Eugenio Bologna

|Apr 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud

|Apr 28, 2018
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.

Ilaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli

Pageof 1

Frequent Collaborators

1 joint publications

Sara Mokbel

1 joint publications

Richard Cathomas

1 joint publications

Pauline Parent

1 joint publications

Kira-Lee Koster